MCM
LLY icon

Maple Capital Management’s Eli Lilly LLY Stock Holding History

Maple Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.6M Sell
47,451
-751
-2% -$761K 2.92% 11
2025
Q4 		$51.8M Buy
48,202
+1,281
+3% +$1.22M 3.26% 9
2025
Q3 		$35.8M Buy
46,921
+154
+0.3% +$115K 2.35% 13
2025
Q2 		$36.5M Buy
46,767
+678
+1% +$527K 2.5% 13
2025
Q1 		$38.1M Sell
46,089
-305
-0.7% -$254K 2.94% 11
2024
Q4 		$35.8M Sell
46,394
-322
-0.7% -$267K 2.64% 12
2024
Q3 		$41.4M Buy
46,716
+123
+0.3% +$111K 3.16% 10
2024
Q2 		$42.2M Buy
46,593
+121
+0.3% +$96.8K 3.42% 8
2024
Q1 		$36.2M Sell
46,472
-950
-2% -$676K 3.29% 10
2023
Q4 		$27.6M Sell
47,422
-2,911
-6% -$1.7M 2.77% 14
2023
Q3 		$27M Sell
50,333
-3,628
-7% -$1.87M 3.08% 12
2023
Q2 		$25.3M Sell
53,961
-290
-0.5% -$122K 2.76% 14
2023
Q1 		$18.6M Sell
54,251
-841
-2% -$284K 2.28% 18
2022
Q4 		$20.2M Sell
55,092
-1,649
-3% -$585K 2.67% 15
2022
Q3 		$20.2M Sell
56,741
-20,059
-26% -$6.36M 2.55% 15
2022
Q2 		$24.9M Buy
76,800
+1,112
+1% +$334K 3.28% 8
2022
Q1 		$21.7M Sell
75,688
-164
-0.2% -$42.2K 2.54% 12
2021
Q4 		$21M Sell
75,852
-1,354
-2% -$343K 2.29% 15
2021
Q3 		$17.8M Sell
77,206
-1,524
-2% -$376K 2.26% 17
2021
Q2 		$20.8M Sell
78,730
-1,280
-2% -$257K 2.51% 13
2021
Q1 		$14.9M Sell
80,010
-146
-0.2% -$28.6K 2.21% 17
2020
Q4 		$13.5M Sell
80,156
-436
-0.5% -$65.1K 2.09% 20
2020
Q3 		$11.5M Buy
80,592
+768
+1% +$119K 1.86% 24
2020
Q2 		$13.1M Sell
79,824
-1,138
-1% -$175K 2.57% 13
2020
Q1 		$11.2M Sell
80,962
-2,047
-2% -$281K 2.8% 13
2019
Q4 		$10.9M Buy
83,009
+682
+0.8% +$79.1K 2.11% 21
2019
Q3 		$9.21M Sell
82,327
-4,463
-5% -$497K 1.98% 24
2019
Q2 		$9.62M Sell
86,790
-4,517
-5% -$532K 2.16% 21
2019
Q1 		$11.8M Sell
91,307
-8,498
-9% -$1.03M 2.79% 11
2018
Q4 		$11.5M Buy
99,805
+470
+0.5% +$52.5K 2.97% 8
2018
Q3 		$10.7M Sell
99,335
-473
-0.5% -$47.3K 2.4% 15
2018
Q2 		$8.52M Buy
99,808
+370
+0.4% +$30.4K 2.1% 19
2018
Q1 		$7.69M Buy
99,438
+1,822
+2% +$147K 1.92% 21
2017
Q4 		$8.24M Buy
97,616
+1,450
+2% +$123K 2.12% 18
2017
Q3 		$8.23M Buy
96,166
+2,270
+2% +$186K 2.21% 15
2017
Q2 		$7.73M Buy
93,896
+4,885
+5% +$399K 2.22% 15
2017
Q1 		$7.49M Sell
89,011
-205
-0.2% -$16.4K 2.21% 14
2016
Q4 		$6.56M Buy
89,216
+926
+1% +$69K 2.06% 17
2016
Q3 		$7.09M Buy
88,290
+2,754
+3% +$220K 2.3% 11
2016
Q2 		$6.74M Sell
85,536
-116
-0.1% -$8.73K 2.46% 10
2016
Q1 		$6.17M Buy
85,652
+11,926
+16% +$902K 2.27% 14
2015
Q4 		$6.21M Buy
73,726
+41,300
+127% +$3.43M 2.2% 15
2015
Q3 		$2.71M Buy
+32,426
New +$2.74M 1.01% 39

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Maple Capital Management's LLY Position: Q1 2026 in Review

Maple Capital Management reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $761K and leaving 47,451 shares worth $43.6M. The position accounts for 2.92% of the portfolio, ranked #11.

Maple Capital Management first reported a position in LLY in Q3 2015 and has held it in 43 quarters since. The position peaked at $51.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Maple Capital Management held 47,451 shares of Eli Lilly worth $43.6M as of Q1 2026.
  • Maple Capital Management sold 751 Eli Lilly shares in Q1 2026, an estimated $761K.
  • Eli Lilly made up 2.92% of Maple Capital Management's portfolio in Q1 2026, its #11 holding.
  • Maple Capital Management first reported a position in Eli Lilly in Q3 2015 and has held it in 43 quarters since.
  • Maple Capital Management's Eli Lilly position peaked at $51.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.